DK1010694T3 - Spiroimidazolinderivater og deres anvendelse som alfa2-adrenerge antagonister og monoamin-genoptagningsblokkere - Google Patents

Spiroimidazolinderivater og deres anvendelse som alfa2-adrenerge antagonister og monoamin-genoptagningsblokkere

Info

Publication number
DK1010694T3
DK1010694T3 DK99403189T DK99403189T DK1010694T3 DK 1010694 T3 DK1010694 T3 DK 1010694T3 DK 99403189 T DK99403189 T DK 99403189T DK 99403189 T DK99403189 T DK 99403189T DK 1010694 T3 DK1010694 T3 DK 1010694T3
Authority
DK
Denmark
Prior art keywords
derivatives
spiroimidazoline
alpha2
monoamine reuptake
adrenergic antagonists
Prior art date
Application number
DK99403189T
Other languages
Danish (da)
English (en)
Inventor
Alex Cordi
Mark Millan
Adrian Newman-Tancredi
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1010694T3 publication Critical patent/DK1010694T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99403189T 1998-12-18 1999-12-17 Spiroimidazolinderivater og deres anvendelse som alfa2-adrenerge antagonister og monoamin-genoptagningsblokkere DK1010694T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9816000A FR2787450B1 (fr) 1998-12-18 1998-12-18 Nouveaux derives spiroimidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1010694T3 true DK1010694T3 (da) 2003-11-24

Family

ID=9534134

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99403189T DK1010694T3 (da) 1998-12-18 1999-12-17 Spiroimidazolinderivater og deres anvendelse som alfa2-adrenerge antagonister og monoamin-genoptagningsblokkere

Country Status (22)

Country Link
US (1) US6172097B1 (ru)
EP (1) EP1010694B1 (ru)
JP (1) JP3457241B2 (ru)
KR (1) KR100472522B1 (ru)
CN (1) CN1149201C (ru)
AT (1) ATE246680T1 (ru)
AU (1) AU760373B2 (ru)
BR (1) BR9905904A (ru)
CA (1) CA2292920C (ru)
DE (1) DE69910156T2 (ru)
DK (1) DK1010694T3 (ru)
EA (1) EA002979B1 (ru)
ES (1) ES2205741T3 (ru)
FR (1) FR2787450B1 (ru)
HK (1) HK1029117A1 (ru)
HU (1) HU225820B1 (ru)
NO (1) NO314402B1 (ru)
NZ (1) NZ501890A (ru)
PL (1) PL202368B1 (ru)
PT (1) PT1010694E (ru)
SI (1) SI1010694T1 (ru)
ZA (1) ZA997735B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
CA2716080C (en) 2008-02-20 2016-12-13 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294185B1 (en) * 1993-03-12 2001-09-25 Auburn University Monomeric and polymeric cyclic amine and N-halamine compounds
FR2707982B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2709306B1 (fr) * 1993-07-20 1995-10-20 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
KR100472522B1 (ko) 2005-03-07
SI1010694T1 (en) 2003-12-31
AU760373B2 (en) 2003-05-15
ATE246680T1 (de) 2003-08-15
AU6529199A (en) 2000-06-22
BR9905904A (pt) 2000-08-29
HU225820B1 (en) 2007-10-29
EA199901049A3 (ru) 2000-08-28
DE69910156T2 (de) 2004-06-09
HUP9904629A2 (hu) 2000-08-28
NO996285D0 (no) 1999-12-17
NO996285L (no) 2000-06-19
EP1010694A3 (fr) 2000-07-26
JP3457241B2 (ja) 2003-10-14
CA2292920C (fr) 2004-01-27
HU9904629D0 (en) 2000-02-28
CN1149201C (zh) 2004-05-12
NZ501890A (en) 2001-03-30
KR20000067830A (ko) 2000-11-25
ZA997735B (en) 2000-06-19
PL337265A1 (en) 2000-06-19
DE69910156D1 (de) 2003-09-11
HK1029117A1 (en) 2001-03-23
EA002979B1 (ru) 2002-12-26
JP2000178257A (ja) 2000-06-27
US6172097B1 (en) 2001-01-09
HUP9904629A3 (en) 2000-12-28
CA2292920A1 (fr) 2000-06-18
ES2205741T3 (es) 2004-05-01
EP1010694B1 (fr) 2003-08-06
CN1264704A (zh) 2000-08-30
EA199901049A2 (ru) 2000-08-28
EP1010694A2 (fr) 2000-06-21
PL202368B1 (pl) 2009-06-30
NO314402B1 (no) 2003-03-17
FR2787450A1 (fr) 2000-06-23
PT1010694E (pt) 2003-10-31
FR2787450B1 (fr) 2001-01-26

Similar Documents

Publication Publication Date Title
EE05103B1 (et) Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
YU68102A (sh) Derivati karboksilne kiseline kao ip antagonisti
HK1070054A1 (en) Arylsulfonyl derivatives with5-ht6 receptor affinity
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
NO20040881L (no) Orale antidiabetes midler.
EP1553096A4 (en) pyrazole
WO2003066594A3 (de) 3-alkanoylamino-propionsäure-derivate als inhibitoren des integrins avss6
NO996284L (no) Nye imidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
IL127177A (en) ANTIPYSYCHOTIC 5-(1, 3, 4, 4a, 5, 9b-HEXAHYDRO-PYRIDO (3, 4-b) INDOL-2-YLALKYL) PYRIMIDIN-4-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK1010694T3 (da) Spiroimidazolinderivater og deres anvendelse som alfa2-adrenerge antagonister og monoamin-genoptagningsblokkere
MXPA04003741A (es) Derivados novedosos de hidroxialquil indolocarbazol, metodo de preparacion y composiciones farmaceuticas que los contienen.
MXPA04001442A (es) Derivados de m-aminofenol y agentes colorantes que contienen estos compuestos.
AP2001002179A0 (en) 2-Aminocarbonyl-9h-purine derivatives.